Year | HBV suspected N (%) | HBV Positive N (%) | HCV Suspected N (%) | HCV Positive N (%) | Both HBV and HCV suspected N (%) | Both HBV and HCV Positive N (%) |
---|---|---|---|---|---|---|
Sex | ||||||
Male | 1317 | 106(8.0) | 481 | 12(2.49) | 36 | 1(2.63) |
Female | 17,956 | 583(3.24) | 924 | 18(1.94) | 18 | 3(16.67) |
Age | ||||||
0–14 | 364 | 8(2.19) | 56 | 1(1.78) | 1 | 1(100.0) |
15–24 | 7085 | 220(3.1) | 404 | 4(0.99) | 21 | 1(4.76) |
25–34 | 8526 | 317(3.71) | 447 | 8(1.78) | 19 | 1(5.26) |
35–44 | 2474 | 103(4.16) | 235 | 6(2.55) | 4 | 0(0.0) |
45–54 | 334 | 16(4.79) | 93 | 7(7.52) | 5 | 1(16.67) |
55–64 | 187 | 6(3.2) | 52 | 2(3.84) | 4 | 0(0.0) |
≥ 65 | 303 | 19(6.27) | 118 | 2(1.69) | 0 | 0(0.0) |
Year | ||||||
2014 | 989 | 91(9.2) | 125 | 7(5.6) | 41 | 0(0.0) |
2015 | 1845 | 66(3.57) | 79 | 10(12.65) | 10 | 3(30.0) |
2016 | 936 | 27(2.88) | 165 | 0(0.0) | 2 | 0(0.0) |
2017 | 3900 | 71(1.82) | 284 | 7(2.46) | 1 | 1(33.34) |
2018 | 4351 | 148(3.4) | 136 | 1(0.73) | 0 | 0(0.0) |
2019 | 7252 | 286(3.94) | 616 | 5(0.81) | 0 | 0(0.0) |